Carcinoma in situ
Carcinoma in situ (CIS) is a term used in medicine to describe a group of abnormal cells. While these cells have the potential to become cancer, they are not yet invasive and therefore are not considered a true cancer. Instead, they are often referred to as pre-cancerous lesions.
Definition
Carcinoma in situ is defined as a group of abnormal cells that are confined to their place of origin. These cells have not yet invaded the basement membrane or other tissues. The term "in situ" is Latin for "in its original place".
Types
There are several types of carcinoma in situ, each named for the type of cells involved and the location in the body where they are found. These include:
- Ductal carcinoma in situ (DCIS): This type of CIS occurs in the milk ducts of the breast.
- Lobular carcinoma in situ (LCIS): This type of CIS occurs in the lobules of the breast.
- Cervical intraepithelial neoplasia (CIN): This is a type of CIS that occurs in the cervix.
- Vulvar intraepithelial neoplasia (VIN): This type of CIS occurs in the vulva.
- Anal intraepithelial neoplasia (AIN): This type of CIS occurs in the anus.
Diagnosis
Carcinoma in situ is often diagnosed through routine screening tests, such as a Pap smear for cervical intraepithelial neoplasia or a mammogram for ductal carcinoma in situ. If these tests detect abnormal cells, further testing may be done to confirm the diagnosis.
Treatment
The treatment for carcinoma in situ depends on the type and location of the abnormal cells. Options may include close monitoring, surgery to remove the abnormal cells, or treatment with radiation or drugs to destroy the cells.
Prognosis
The prognosis for carcinoma in situ is generally good, as these cells have not yet become invasive. However, if left untreated, they may develop into invasive cancer.
See also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


